A carregar...
Treatment Of Magnesium-L-Threonate Elevates The Magnesium Level In The Cerebrospinal Fluid And Attenuates Motor Deficits And Dopamine Neuron Loss In A Mouse Model Of Parkinson’s disease
PURPOSE: Epidemiology research has demonstrated that magnesium (Mg) deficiency is associated with a high incidence of Parkinson’s disease (PD). It is known that the systemic administration of MgSO(4) is not able to elevate the Mg concentration in cerebrospinal fluid (CSF). This study aims to verify...
Na minha lista:
| Publicado no: | Neuropsychiatr Dis Treat |
|---|---|
| Main Authors: | , , , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Dove
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6857673/ https://ncbi.nlm.nih.gov/pubmed/31806980 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/NDT.S230688 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|